Cenforce-D Sildenafil 100 mg + Dapoxetine 60 mg Tablets

Cenforce-D Sildenafil 100 mg + Dapoxetine 60 mg Tablets

Cenforce-D is presented here solely for factual product-label information. Its stated composition and strength must be verified against the original packaging and official manufacturer documentation. Sildenafil is a PDE5 inhibitor used for erectile dysfunction. Dapoxetine is a short-acting selective serotonin reuptake inhibitor used in certain adult men diagnosed with premature ejaculation. The combination requires an individual medical assessment because each ingredient has separate contraindications and interaction risks.

Product details

• Active ingredients: Sildenafil citrate and dapoxetine
• Labelled strength: Sildenafil 100 mg + dapoxetine 60 mg
• Dosage form: Tablet
• Intended use: Adults assessed by a licensed healthcare professional as requiring both active ingredients

Before use

A clinician must review heart and blood-pressure conditions, fainting history, mood or psychiatric history, liver and kidney function, bleeding risk, eye conditions, and every medicine, supplement, or recreational substance used. Do not combine this product with any other sildenafil, tadalafil, vardenafil, dapoxetine, erectile-dysfunction treatment, or premature-ejaculation treatment.

Important safety information

Never use the sildenafil component with nitrates used for chest pain, nitric-oxide donors such as amyl nitrite (“poppers”), or riociguat, as a dangerous fall in blood pressure may occur. Sildenafil may also be unsuitable where sexual activity is medically inadvisable, after certain recent cardiovascular events, or with severe low blood pressure, serious liver disease, or particular hereditary eye disorders.

Dapoxetine can cause dizziness, light-headedness, and fainting. Avoid alcohol because it can increase these effects and the risk of injury. Dapoxetine has important interactions and must not be combined with monoamine oxidase inhibitors (MAOIs), thioridazine, other serotonergic medicines—including many SSRIs, SNRIs, tricyclic antidepressants, tramadol, lithium, linezolid, or St John’s wort—or strong CYP3A4 inhibitors unless a licensed prescriber has specifically confirmed suitability and the required washout period.

Potential effects include headache, flushing, indigestion, nasal congestion, nausea, diarrhoea, dizziness, and sleep disturbance. Stop use and obtain urgent medical help for chest pain, fainting, seizure, severe allergy, marked agitation or other symptoms suggesting serotonin syndrome, sudden loss of vision or hearing, or an erection lasting more than four hours.

Storage and quality checks

Keep in the original packaging, out of the sight and reach of children, and protect from heat and moisture. Before use, check that the tamper seal, batch details, and expiry date are intact and legible. Do not use a damaged or visibly altered package.

Regulatory notice

The official references below concern the individual active ingredients and do not establish authorization of this exact fixed-combination presentation. Its authorization, dispensing classification, and permitted sale depend on the supplied manufacturer documentation and destination country. Local prescription and pharmacy rules must be followed.

This information does not replace the supplied patient leaflet or advice from a doctor or pharmacist.

• Medical reference: European Medicines Agency — Viagra (sildenafil)
• Medical reference: HPRA — Priligy 60 mg (dapoxetine)